Identification of prognostic biomarkers for cholangiocarcinoma by combined analysis of molecular characteristics of clinical MVI subtypes and molecular subtypes

被引:0
|
作者
Li, Ming-Yue [1 ]
Liu, Ya-Hui [1 ]
Wei, Feng [1 ]
Zhang, Ping [1 ]
Sun, Xiao-Dong [1 ]
Wang, Meng [1 ]
Du, Xiao-Hong [1 ]
Ye, Jun-Feng [1 ]
Qiu, Wei [1 ]
Shi, Xiao-Ju [1 ]
Ji, Bai [1 ]
Wang, Ying-Chao [1 ]
Jiang, Chao [1 ]
Chai, Wen-Gang [1 ]
Huang, Bo [1 ]
Liu, Xing-Kai [1 ]
Chen, Qing-Min [1 ]
Fu, Yu [1 ]
Hu, Xin-Tong [2 ]
Chen, Li-Guo [2 ]
He, Jia-Xue [2 ]
Chai, Kai-Yuan [1 ]
Gou, Zhao-Ming [1 ]
Yang, Tian [1 ,3 ]
Wang, Guang-Yi [1 ]
Jiang, Yan-Fang [2 ]
Fan, Zhong-Qi [1 ]
Lv, Guo-Yue [1 ]
机构
[1] Jilin Univ, Gen Surg Ctr, Dept Hepatobiliary & Pancreat Surg, Hosp 1, 1 Xinmin St, Changchun 130021, Jilin, Peoples R China
[2] Jilin Univ, Genet Diag Ctr, Key Lab Organ Regenerat & Transplantat, Minist Educ,Hosp 1, 1 Xinmin St, Changchun 130021, Jilin, Peoples R China
[3] Navy Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepatobiliary Surg, Mil Med Univ 2, Shanghai, Peoples R China
关键词
Cholangiocarcinoma; MVI; Molecular classification; Prognostic marker; INTRAHEPATIC CHOLANGIOCARCINOMA; CLASSIFICATION;
D O I
10.1016/j.ygeno.2024.110889
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Cholangiocarcinoma (CCA) is widely noted for its high degree of malignancy, rapid progression, and limited therapeutic options. This study was carried out on transcriptome data of 417 CCA samples from different anatomical locations. The effects of lipid metabolism related genes and immune related genes as CCA classifiers were compared. Key genes were derived from MVI subtypes and better molecular subtypes. Pathways such as epithelial mesenchymal transition (EMT) and cell cycle were significantly activated in MVI-positive group. CCA patients were classified into three (four) subtypes based on lipid metabolism (immune) related genes, with better prognosis observed in lipid metabolism-C1, immune-C2, and immune-C4. IPTW analysis found that the prognosis of lipid metabolism-C1 was significantly better than that of lipid metabolism-C2 + C3 before and after correction. KRT16 was finally selected as the key gene. And knockdown of KRT16 inhibited proliferation, migration and invasion of CCA cells.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer
    Seon-Kyu Kim
    Hee-Jin Kim
    Jong-Lyul Park
    Haejeong Heo
    Seon-Young Kim
    Sang-Il Lee
    Kyu-Sang Song
    Woo-Ho Kim
    Yong Sung Kim
    Gastric Cancer, 2020, 23 : 473 - 482
  • [32] Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
    Chaisaingmongkol, Jittiporn
    Budhu, Anuradha
    Dang, Hien
    Rabibhadana, Siritida
    Pupacdi, Benjarath
    Kwon, So Mee
    Forgues, Marshonna
    Pomyen, Yotsawat
    Bhudhisawasdi, Vajarabhongsa
    Lertprasertsuke, Nirush
    Chotirosniramit, Anon
    Pairojkul, Chawalit
    Auewarakul, Chirayu U.
    Sricharunrat, Thaniya
    Phornphutkul, Kannika
    Sangrajrang, Suleeporn
    Cam, Maggie
    He, Ping
    Hewitt, Stephen M.
    Ylaya, Kris
    Wu, Xiaolin
    Andersen, Jesper B.
    Thorgeirsson, Snorri S.
    Waterfall, Joshua J.
    Zhu, Yuelin J.
    Walling, Jennifer
    Stevenson, Holly S.
    Edelman, Daniel
    Meltzer, Paul S.
    Loffredo, Christopher A.
    Hama, Natsuko
    Shibata, Tatsuhiro
    Wiltrout, Robert H.
    Harris, Curtis C.
    Mahidol, Chulabhorn
    Ruchirawat, Mathuros
    Wang, Xin W.
    CANCER CELL, 2017, 32 (01) : 57 - +
  • [33] Molecular subtypes as potential biomarkers in renal cell carcinoma
    Chehade, Chadi Hage
    Agarwal, Neeraj
    CANCER CELL, 2024, 42 (05) : 736 - 738
  • [34] A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer
    Chen, Shuangfeng
    Li, Yuebo
    Qian, Lili
    Deng, Sisi
    Liu, Luwen
    Xiao, Weihua
    Zhou, Ying
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [35] Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
    Dai, Xiaofeng
    Xiang, Liangjian
    Li, Ting
    Bai, Zhonghu
    JOURNAL OF CANCER, 2016, 7 (10): : 1281 - 1294
  • [36] Identification of Distinct Molecular Subtypes of Endometrioid Adenocarcinoma
    Lei, Jia
    Yan, Shuping
    Guo, Xiangqian
    Wang, Fengling
    Zhang, Guosen
    Kan, Quancheng
    Guo, Ruixia
    FRONTIERS IN GENETICS, 2021, 12
  • [37] Histological, molecular and clinical analysis of the two subtypes of atypical leiomyoma
    Zhang, Qing
    Ubago, Julianne
    Poropatich, Kate Olmstead
    Dong, Ruifen
    Wei, Jian-Jun
    Kong, Beihua
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S39 - S39
  • [38] Two Subtypes of Atypical Leiomyoma: Clinical, Histologic, and Molecular Analysis
    Ubago, Julianne M.
    Zhang, Qing
    Kim, Julie J.
    Kong, Beihua
    Wei, Jian-Jun
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (07) : 923 - 933
  • [39] ROBUSTNESS OF BREAST CANCER MOLECULAR SUBTYPES IDENTIFICATION
    Haibe-Kains, B.
    Culhane, A.
    Desmedt, C.
    Bontempi, G.
    Quackenbush, J.
    Sotiriou, C.
    ANNALS OF ONCOLOGY, 2010, 21 : 49 - 49
  • [40] Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes
    Schlitter, Anna Melissa
    Segler, Angela
    Steiger, Katja
    Michalski, Christoph W.
    Jaeger, Carsten
    Konukiewitz, Bjoern
    Pfarr, Nicole
    Endris, Volker
    Bettstetter, Markus
    Kong, Bo
    Regel, Ivonne
    Kleeff, Joerg
    Kloeppel, Guenter
    Esposito, Irene
    SCIENTIFIC REPORTS, 2017, 7